BALYASNY ASSET MANAGEMENT L.P. - CYTEK BIOSCIENCES INC ownership

CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 102 filers reported holding CYTEK BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of CYTEK BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$75,403
-89.2%
13,660
-83.3%
0.00%
-100.0%
Q2 2023$699,973
-37.6%
81,964
-32.8%
0.00%
-33.3%
Q1 2023$1,121,355
-10.7%
122,019
-0.8%
0.00%0.0%
Q4 2022$1,255,963123,0130.00%
Other shareholders
CYTEK BIOSCIENCES INC shareholders Q1 2023
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,100,000$22,533,00012.24%
Miura Global Management 1,649,400$17,698,00012.14%
RA Capital Management 13,381,054$143,578,0003.83%
HHLR ADVISORS, LTD. 8,757,030$93,963,0002.01%
PURA VIDA INVESTMENTS, LLC 477,164$5,120,0000.30%
RTW INVESTMENTS, LP 916,838$9,838,0000.25%
Glenview Capital Management 500,000$5,365,0000.13%
GSA CAPITAL PARTNERS LLP 73,743$791,0000.12%
Parkwood LLC 42,292$454,0000.08%
Point72 Asset Management, L.P. 1,536,079$16,482,0000.07%
View complete list of CYTEK BIOSCIENCES INC shareholders